Cite

    Teh, J. J., Kang, S., Leonard, A., Zhang, J., Hu, J., Hamilton, A. L., Wilson-O'Brien, A., Trakman, G. L., Lin, W., Ching, J., Sung, J. J. Y., Yu, J., Ng, S. C., Kamm, M. A., & Morrison, M. (n.d.). dOP48 Key Anti-Inflammatory Faecalibacterium prausnitzii is Heterogeneous and Diverse in the East and West and in Health and Crohn's disease. The ENIGMA study. Journal of Crohn's and colitis, 17, i116–i119. http://access.bl.uk/ark:/81055/vdc_100179843994.0x000011